Riskpilot← Back to searchSign inGet full accessAbbott Oy
OYActiveY-tunnus 0803151-4Karvaamokuja 2-AWholesale of pharmaceutical and medical goods · NACE 4646Est. 199036 employees
Revenue 2024
EUR 80,8M
+10797% vs 2023
EBITDA margin
3.4%
+842% vs 2023
Equity ratio
45.3%
Financial strength
Net profit 2024
EUR 1,4M
-24% vs 2023
| Revenue | EUR 80,8M | +10797% |
| EBITDA | EUR 2,7M | +842% |
| Net profit | EUR 1,4M | -24% |
| Total assets | EUR 30,9M | +4% |
| Equity | EUR 14M | +12% |
| Employees | 36 | — |
Legal name
Abbott Oy
Y-tunnus number
0803151-4
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. helmikuuta 1990
Share capital
EUR 8 025
Employees
36 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on harjoittaa lääkkeiden, farmaseuttisten tuotteiden, luontaistuotteiden ja lisäravinteiden maahantuontia, markkinointia ja myyntiä. Yhtiö myös maahantuo, markkinoi, myy ja välittää sairaala- ja laboratoriolaitteita ja niihin liittyviä tuotteita. Yhtiö voi harjoittaa ja tukea tutkimus- ja tuotekehitystyötä sekä harjoittaa konsultointia ja omistaa toimintaansa varten arvopapereita ja kiinteistöjä.
Address
Karvaamokuja 2-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 60 168 | 68 478 | 71 491 | 741 | 80 767 |
| Staff expenses | −3 793 | −3 717 | −3 704 | −4 079 | −4 099 |
| EBITDA | 5 083 | 6 481 | 6 668 | 289 | 2 725 |
| Depreciation & amort. | −1 271 | −1 029 | −856 | −295 | −376 |
| EBIT | 3 812 | 5 452 | 5 812 | −6 | 2 349 |
| Net financials | 46 | 6 | 133 | 166 | −259 |
| Profit before tax | 4 223 | 5 934 | 6 116 | 2 395 | 1 866 |
| Tax | 776 | 1 097 | 1 201 | 483 | 422 |
| Net profit | 3 447 | 4 838 | 4 915 | 1 912 | 1 444 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 35 379 | 42 665 | 43 549 | 29 787 | 30 855 |
| Equity | 24 397 | 28 853 | 33 632 | 12 544 | 13 989 |
| Long-term debt | 2 647 | 2 306 | 2 184 | 23 | 0 |
| Short-term debt | 8 335 | 11 507 | 7 732 | 17 220 | 16 629 |
| Total debt | 10 982 | 13 812 | 9 917 | 17 242 | 16 641 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
45.3%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
2.62×
This company
1.12×
Market median
+134% vs market
20202024
Debt / equity
1.21×
This company
0.62×
Market median
-95% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
OM Chief Executive Officer | Chief Executive Officer | 2016 – 2023 |
| Audit | 2014 – 2023 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2016 | |
| Former (2) | ||
| Board of Directors | 2016 – 2019 | |
| Board of Directors | 2019 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Abbott Oy 
Abbott Medical Finland OyBoard members of Abbott Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Andreas Almroth | Chief Executive Officer | 0 companies |
| Ole Martin Alfstad Christiansen | Chief Executive Officer | 0 companies |
| Hanna Reetta Katariina Kaskimies | Audit | 0 companies |
| Brian B Yoor | Board of Directors | 0 companies |
| Bradley Jay Slater | Board of Directors | 0 companies |
| Benjamin Edward Oosterbaan | Board of Directors | 0 companies |
| Marko Seppo Juhani Lahikainen | Board of Directors | 0 companies |